Jun. 4 at 12:04 PM
$DGNX To help businesses navigate tightening global frameworks, like the EU Forced Labour Regulation and CSDDD, Diginex [NASDAQ: DGNX] has launched Risk-to-Remedy, an end-to-end supply chain due diligence solution.
By combining LUMEN’s risk assessment, APPRISE’s direct worker engagement, and The Remedy Project’s grievance expertise, the platform integrates worker-level evidence with regulator-ready reporting. This allows companies to demonstrate compliance with defensible data rather than relying on unverified statements, protecting organizations from product bans, fines, and reputational damage.
Read today's press release for more details: https://ir.diginex.com/news-releases/news-release-details/diginex-expands-supply-chain-end-end-product-suite-amid